TTM
$1.52B
YoY change
+37.2%
5Y CAGR
+17.6%
Peak year (2025)
$1.40B
Cumulative net income
$10.12B
Net Income history chart for ResMed (RMD) from 1993 to 2025
Latest: $1.40B
Net Income growth chart for ResMed (RMD) from 1993 to 2025
Latest: +37.2%
Net Income history table for ResMed (RMD) from 1993 to 2025
| 2025 | $1.40B | +37.2% | +$379.77M | ||
| 2024 | $1.02B | +13.7% | +$123.39M | ||
| 2023 | $897.56M | +15.2% | +$118.12M | ||
| 2022 | $779.44M | +64.3% | +$304.93M | ||
| 2021 | $474.50M | -23.7% | −$147.17M | ||
| 2020 | $621.67M | +53.7% | +$217.08M | ||
| 2019 | $404.59M | +28.2% | +$89.00M | ||
| 2018 | $315.59M | -7.8% | −$26.70M | ||
| 2017 | $342.28M | -2.9% | −$10.12M | ||
| 2016 | $352.41M | -0.1% | −$478.00K | ||
| 2015 | $352.89M | +2.2% | +$7.61M | ||
| 2014 | $345.27M | +12.4% | +$38.14M | ||
| 2013 | $307.13M | +20.5% | +$52.28M | ||
| 2012 | $254.85M | +12.3% | +$27.86M | ||
| 2011 | $226.99M | +19.4% | +$36.90M | ||
| 2010 | $190.09M | +29.8% | +$43.64M | ||
| 2009 | $146.45M | +32.8% | +$36.15M | ||
| 2008 | $110.30M | +66.4% | +$44.00M | ||
| 2007 | $66.30M | -24.8% | −$21.91M | ||
| 2006 | $88.21M | +36.2% | +$23.43M | ||
| 2005 | $64.78M | +13.1% | +$7.50M | ||
| 2004 | $57.28M | +25.3% | +$11.55M | ||
| 2003 | $45.73M | +21.9% | +$8.22M | ||
| 2002 | $37.51M | +222.5% | +$25.88M | ||
| 2001 | $11.63M | -47.7% | −$10.60M | ||
| 2000 | $22.23M | +38.0% | +$6.13M | ||
| 1999 | $16.10M | +51.9% | +$5.50M | ||
| 1998 | $10.60M | +41.3% | +$3.10M | ||
| 1997 | $7.50M | +66.7% | +$3.00M | ||
| 1996 | $4.50M | +60.7% | +$1.70M | ||
| 1995 | $2.80M | +133.3% | +$1.60M | ||
| 1994 | $1.20M | +50.0% | +$400.00K | ||
| 1993 | $800.00K | — | — |
- 2025$1.40B+37.2%
- 2024$1.02B+13.7%
- 2023$897.56M+15.2%
- 2022$779.44M+64.3%
- 2021$474.50M-23.7%
- 2020$621.67M+53.7%
- 2019$404.59M+28.2%
- 2018$315.59M-7.8%
- 2017$342.28M-2.9%
- 2016$352.41M-0.1%
- 2015$352.89M+2.2%
- 2014$345.27M+12.4%
- 2013$307.13M+20.5%
- 2012$254.85M+12.3%
- 2011$226.99M+19.4%
- 2010$190.09M+29.8%
- 2009$146.45M+32.8%
- 2008$110.30M+66.4%
- 2007$66.30M-24.8%
- 2006$88.21M+36.2%
- 2005$64.78M+13.1%
- 2004$57.28M+25.3%
- 2003$45.73M+21.9%
- 2002$37.51M+222.5%
- 2001$11.63M-47.7%
- 2000$22.23M+38.0%
- 1999$16.10M+51.9%
- 1998$10.60M+41.3%
- 1997$7.50M+66.7%
- 1996$4.50M+60.7%
- 1995$2.80M+133.3%
- 1994$1.20M+50.0%
- 1993$800.00K—
Net Income values are taken from ResMed's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Net Income at ResMed (RMD)
According to ResMed's latest reported financial statements, the company's current net income (TTM) is $1.52B. Net income is the bottom-line profit after all expenses — cost of goods sold, operating expenses, interest, and taxes — are subtracted from revenue. It is the figure used to compute earnings per share (EPS) and is the residual available to shareholders.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
As of the 2025 fiscal year, ResMed (RMD) reported net income of $1.40B – surged 37.2% year-over-year.
Looking at the 2020–2025 (5 years) stretch, ResMed net income compounded at +17.6% per year, sustaining 4 straight years of year-over-year growth.
$1.40B stands as the all-time-high annual net income, posted in 2025, against a low of $800.00K during 1993.
ResMed Net Income by Year
ResMed Net Income 2025: $1.40B
ResMed posted net income of $1.40B in 2025, surged 37.2% from 2024. This figure represents the highest annual value in the available history.
ResMed Net Income 2024: $1.02B
In 2024, ResMed reported net income of $1.02B, grew 13.7% from 2023.
ResMed Net Income 2023: $897.56M
ResMed net income in 2023 was $897.56M, grew 15.2% from 2022.
ResMed Net Income 2022: $779.44M
2022's net income for ResMed came in at $779.44M, surged 64.3% from 2021.
ResMed Net Income 2021: $474.50M
ResMed net income in 2021 was $474.50M.
See more financial history for ResMed (RMD).
Sector peers by Net Income
Healthcare peers of ResMed (RMD), ranked by their latest net income
| $26.80B | |
| $20.64B | |
| $18.25B | |
| $15.97B | |
| $12.06B | |
| $10.26B | |
| $7.71B | |
| $4.23B |
- $26.80B
- $20.64B
- $18.25B
- $15.97B
- $12.06B
- $10.26B
- $7.71B
- $4.23B
Frequently asked questions
ResMed (RMD) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation